Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Total 13F shares
-
1,842,038
-
Share change
-
-201,774
-
Total reported value
-
$4,363,682
-
Price per share
-
$2.37
-
Number of holders
-
20
-
Value change
-
-$463,906
-
Number of buys
-
4
-
Number of sells
-
12
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q4 2024
As of 31 Dec 2024,
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,842,038 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., TWO SIGMA INVESTMENTS, LP, and STATE STREET CORP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.